 | • レポートコード：D0GIR-01606 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肝抗ウイルス薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。肝抗ウイルス薬の種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデホビル、テルビブジン、その他）、用途別市場規模（病院、在宅医療、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Teva Pharmaceutical Industries、Apotex、Cipla、Bristol-Myers Squibb、Aurobindo Pharma、Zydus Cadila、Mylan、Hetero Drug、Prinston Pharmaceutical、Gilead Sciences ・地域別グローバル市場分析 2015年-2020年 ・肝抗ウイルス薬の北米市場（アメリカ、カナダ、メキシコ） ・肝抗ウイルス薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肝抗ウイルス薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肝抗ウイルス薬の南米市場（ブラジル、アルゼンチン） ・肝抗ウイルス薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：エンテカビル、テノホビル、ラミブジン、アデホビル、テルビブジン、その他 ・用途別分析：病院、在宅医療、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Hepatic Antiviral Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Hepatic Antiviral Drug sales will be xx in 2020 from Hepatic Antiviral Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Hepatic Antiviral Drug market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Hepatic Antiviral Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Hepatic Antiviral Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Hepatic Antiviral Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hepatic Antiviral Drug market has been segmented into:
Entecavir
Tenofovir
lamivudine
Adefovir
Telbivudine
Others
By Application, Hepatic Antiviral Drug has been segmented into:
Hospitals
Homecare
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hepatic Antiviral Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Hepatic Antiviral Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hepatic Antiviral Drug market.
The report offers in-depth assessment of the growth and other aspects of the Hepatic Antiviral Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Hepatic Antiviral Drug Market Share Analysis
Hepatic Antiviral Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hepatic Antiviral Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hepatic Antiviral Drug sales, revenue and market share for each player covered in this report.
The major players covered in Hepatic Antiviral Drug are:
Teva Pharmaceutical Industries
Apotex
Cipla
Bristol-Myers Squibb
Aurobindo Pharma
Zydus Cadila
Mylan
Hetero Drug
Prinston Pharmaceutical
Gilead Sciences
Among other players domestic and global, Hepatic Antiviral Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Hepatic Antiviral Drug Market Overview
1.1 Product Overview and Scope of Hepatic Antiviral Drug
1.2 Classification of Hepatic Antiviral Drug by Type
1.2.1 Global Hepatic Antiviral Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hepatic Antiviral Drug Revenue Market Share by Type in 2019
1.2.3 Entecavir
1.2.4 Tenofovir
1.2.5 lamivudine
1.2.6 Adefovir
1.2.7 Telbivudine
1.2.8 Others
1.3 Global Hepatic Antiviral Drug Market by Application
1.3.1 Overview: Global Hepatic Antiviral Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.3.5 Others
1.4 Global Hepatic Antiviral Drug Market by Regions
1.4.1 Global Hepatic Antiviral Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hepatic Antiviral Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hepatic Antiviral Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hepatic Antiviral Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hepatic Antiviral Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hepatic Antiviral Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hepatic Antiviral Drug Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Hepatic Antiviral Drug Industry Impact
1.5.1 COVID-19 Potential Implications for the Hepatic Antiviral Drug
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Hepatic Antiviral Drug
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Teva Pharmaceutical Industries
2.1.1 Teva Pharmaceutical Industries Details
2.1.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva Pharmaceutical Industries SWOT Analysis
2.1.4 Teva Pharmaceutical Industries Product and Services
2.1.5 Teva Pharmaceutical Industries Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Apotex
2.2.1 Apotex Details
2.2.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Apotex SWOT Analysis
2.2.4 Apotex Product and Services
2.2.5 Apotex Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cipla
2.3.1 Cipla Details
2.3.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cipla SWOT Analysis
2.3.4 Cipla Product and Services
2.3.5 Cipla Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb SWOT Analysis
2.4.4 Bristol-Myers Squibb Product and Services
2.4.5 Bristol-Myers Squibb Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aurobindo Pharma
2.5.1 Aurobindo Pharma Details
2.5.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aurobindo Pharma SWOT Analysis
2.5.4 Aurobindo Pharma Product and Services
2.5.5 Aurobindo Pharma Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zydus Cadila
2.6.1 Zydus Cadila Details
2.6.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Zydus Cadila SWOT Analysis
2.6.4 Zydus Cadila Product and Services
2.6.5 Zydus Cadila Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hetero Drug
2.8.1 Hetero Drug Details
2.8.2 Hetero Drug Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Hetero Drug SWOT Analysis
2.8.4 Hetero Drug Product and Services
2.8.5 Hetero Drug Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Prinston Pharmaceutical
2.9.1 Prinston Pharmaceutical Details
2.9.2 Prinston Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Prinston Pharmaceutical SWOT Analysis
2.9.4 Prinston Pharmaceutical Product and Services
2.9.5 Prinston Pharmaceutical Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Gilead Sciences
2.10.1 Gilead Sciences Details
2.10.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Gilead Sciences SWOT Analysis
2.10.4 Gilead Sciences Product and Services
2.10.5 Gilead Sciences Hepatic Antiviral Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hepatic Antiviral Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hepatic Antiviral Drug Players Market Share
3.2.2 Top 10 Hepatic Antiviral Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hepatic Antiviral Drug Revenue and Market Share by Regions
4.2 North America Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
4.5 South America Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
5 North America Hepatic Antiviral Drug Revenue by Countries
5.1 North America Hepatic Antiviral Drug Revenue by Countries (2015-2020)
5.2 USA Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
6 Europe Hepatic Antiviral Drug Revenue by Countries
6.1 Europe Hepatic Antiviral Drug Revenue by Countries (2015-2020)
6.2 Germany Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
6.3 UK Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
6.4 France Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hepatic Antiviral Drug Revenue by Countries
7.1 Asia-Pacific Hepatic Antiviral Drug Revenue by Countries (2015-2020)
7.2 China Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
7.5 India Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
8 South America Hepatic Antiviral Drug Revenue by Countries
8.1 South America Hepatic Antiviral Drug Revenue by Countries (2015-2020)
8.2 Brazil Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hepatic Antiviral Drug by Countries
9.1 Middle East & Africa Hepatic Antiviral Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hepatic Antiviral Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Hepatic Antiviral Drug Market Forecast by Type (2019-2024)
10.3 Entecavir Revenue Growth Rate (2015-2025)
10.4 Tenofovir Revenue Growth Rate (2015-2025)
10.5 lamivudine Revenue Growth Rate (2015-2025)
10.6 Adefovir Revenue Growth Rate (2015-2025)
10.7 Telbivudine Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Hepatic Antiviral Drug Market Segment by Application
11.1 Global Hepatic Antiviral Drug Revenue Market Share by Application (2015-2020)
11.2 Hepatic Antiviral Drug Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Homecare Revenue Growth (2015-2020)
11.5 Clinics Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Hepatic Antiviral Drug Market Size Forecast (2021-2025)
12.1 Global Hepatic Antiviral Drug Market Size Forecast (2021-2025)
12.2 Global Hepatic Antiviral Drug Market Forecast by Regions (2021-2025)
12.3 North America Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
12.4 Europe Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
12.6 South America Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Hepatic Antiviral Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hepatic Antiviral Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hepatic Antiviral Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hepatic Antiviral Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Hepatic Antiviral Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 7. Teva Pharmaceutical Industries Hepatic Antiviral Drug Major Business
Table 8. Teva Pharmaceutical Industries Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 9. Teva Pharmaceutical Industries SWOT Analysis
Table 10. Teva Pharmaceutical Industries Hepatic Antiviral Drug Product and Solutions
Table 11. Teva Pharmaceutical Industries Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Apotex Corporate Information, Location and Competitors
Table 13. Apotex Hepatic Antiviral Drug Major Business
Table 14. Apotex Hepatic Antiviral Drug Total Revenue (USD Million) (2018-2019)
Table 15. Apotex SWOT Analysis
Table 16. Apotex Hepatic Antiviral Drug Product and Solutions
Table 17. Apotex Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Cipla Corporate Information, Location and Competitors
Table 19. Cipla Hepatic Antiviral Drug Major Business
Table 20. Cipla Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 21. Cipla SWOT Analysis
Table 22. Cipla Hepatic Antiviral Drug Product and Solutions
Table 23. Cipla Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 25. Bristol-Myers Squibb Hepatic Antiviral Drug Major Business
Table 26. Bristol-Myers Squibb Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 27. Bristol-Myers Squibb SWOT Analysis
Table 28. Bristol-Myers Squibb Hepatic Antiviral Drug Product and Solutions
Table 29. Bristol-Myers Squibb Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Aurobindo Pharma Corporate Information, Location and Competitors
Table 31. Aurobindo Pharma Hepatic Antiviral Drug Major Business
Table 32. Aurobindo Pharma Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 33. Aurobindo Pharma SWOT Analysis
Table 34. Aurobindo Pharma Hepatic Antiviral Drug Product and Solutions
Table 35. Aurobindo Pharma Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Zydus Cadila Corporate Information, Location and Competitors
Table 37. Zydus Cadila Hepatic Antiviral Drug Major Business
Table 38. Zydus Cadila Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 39. Zydus Cadila SWOT Analysis
Table 40. Zydus Cadila Hepatic Antiviral Drug Product and Solutions
Table 41. Zydus Cadila Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Mylan Corporate Information, Location and Competitors
Table 43. Mylan Hepatic Antiviral Drug Major Business
Table 44. Mylan Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 45. Mylan SWOT Analysis
Table 46. Mylan Hepatic Antiviral Drug Product and Solutions
Table 47. Mylan Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Hetero Drug Corporate Information, Location and Competitors
Table 49. Hetero Drug Hepatic Antiviral Drug Major Business
Table 50. Hetero Drug Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 51. Hetero Drug SWOT Analysis
Table 52. Hetero Drug Hepatic Antiviral Drug Product and Solutions
Table 53. Hetero Drug Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Prinston Pharmaceutical Corporate Information, Location and Competitors
Table 55. Prinston Pharmaceutical Hepatic Antiviral Drug Major Business
Table 56. Prinston Pharmaceutical Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 57. Prinston Pharmaceutical SWOT Analysis
Table 58. Prinston Pharmaceutical Hepatic Antiviral Drug Product and Solutions
Table 59. Prinston Pharmaceutical Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Gilead Sciences Corporate Information, Location and Competitors
Table 61. Gilead Sciences Hepatic Antiviral Drug Major Business
Table 62. Gilead Sciences Hepatic Antiviral Drug Total Revenue (USD Million) (2017-2018)
Table 63. Gilead Sciences SWOT Analysis
Table 64. Gilead Sciences Hepatic Antiviral Drug Product and Solutions
Table 65. Gilead Sciences Hepatic Antiviral Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Hepatic Antiviral Drug Revenue (Million USD) by Players (2015-2020)
Table 67. Global Hepatic Antiviral Drug Revenue Share by Players (2015-2020)
Table 68. Global Hepatic Antiviral Drug Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Hepatic Antiviral Drug Revenue Market Share by Regions (2015-2020)
Table 70. North America Hepatic Antiviral Drug Revenue by Countries (2015-2020)
Table 71. North America Hepatic Antiviral Drug Revenue Market Share by Countries (2015-2020)
Table 72. Europe Hepatic Antiviral Drug Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Hepatic Antiviral Drug Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Hepatic Antiviral Drug Revenue by Countries (2015-2020)
Table 75. South America Hepatic Antiviral Drug Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Hepatic Antiviral Drug Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Hepatic Antiviral Drug Revenue Market Share by Countries (2015-2020)
Table 78. Global Hepatic Antiviral Drug Revenue (Million USD) by Type (2015-2020)
Table 79. Global Hepatic Antiviral Drug Revenue Share by Type (2015-2020)
Table 80. Global Hepatic Antiviral Drug Revenue Forecast by Type (2021-2025)
Table 81. Global Hepatic Antiviral Drug Revenue by Application (2015-2020)
Table 82. Global Hepatic Antiviral Drug Revenue Share by Application (2015-2020)
Table 83. Global Hepatic Antiviral Drug Revenue Forecast by Application (2021-2025)
Table 84. Global Hepatic Antiviral Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hepatic Antiviral Drug Picture
Figure 2. Global Hepatic Antiviral Drug Revenue Market Share by Type in 2019
Figure 3. Entecavir Picture
Figure 4. Tenofovir Picture
Figure 5. lamivudine Picture
Figure 6. Adefovir Picture
Figure 7. Telbivudine Picture
Figure 8. Others Picture
Figure 9. Hepatic Antiviral Drug Revenue Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Homecare Picture
Figure 12. Clinics Picture
Figure 13. Others Picture
Figure 14. Global Hepatic Antiviral Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Hepatic Antiviral Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Hepatic Antiviral Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Hepatic Antiviral Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Hepatic Antiviral Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Hepatic Antiviral Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Hepatic Antiviral Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Hepatic Antiviral Drug Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Hepatic Antiviral Drug Revenue Market Share in 2019
Figure 23. Global Top 10 Players Hepatic Antiviral Drug Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Hepatic Antiviral Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Hepatic Antiviral Drug Revenue Market Share by Regions (2015-2020)
Figure 27. Global Hepatic Antiviral Drug Revenue Market Share by Regions in 2018
Figure 28. North America Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 29. Europe Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 31. South America Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 33. North America Hepatic Antiviral Drug Revenue Market Share by Countries (2015-2020)
Figure 34. North America Hepatic Antiviral Drug Revenue Market Share by Countries in 2019
Figure 35. USA Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 36. Canada Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 38. Europe Hepatic Antiviral Drug Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Hepatic Antiviral Drug Revenue Market Share by Countries in 2019
Figure 40. Germany Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 41. UK Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 42. France Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 43. Russia Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 44. Italy Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Hepatic Antiviral Drug Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Hepatic Antiviral Drug Revenue Market Share by Countries in 2019
Figure 47. China Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 48. Japan Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 49. Korea Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 50. India Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 52. South America Hepatic Antiviral Drug Revenue Market Share by Countries (2015-2020)
Figure 53. South America Hepatic Antiviral Drug Revenue Market Share by Countries in 2019
Figure 54. Brazil Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Hepatic Antiviral Drug Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Hepatic Antiviral Drug Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 59. UAE Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Hepatic Antiviral Drug Revenue and Growth Rate (2015-2020)
Figure 62. Global Hepatic Antiviral Drug Revenue Share by Type (2015-2020)
Figure 63. Global Hepatic Antiviral Drug Revenue Share by Type in 2019
Figure 64. Global Hepatic Antiviral Drug Market Share Forecast by Type (2021-2025)
Figure 65. Global Entecavir Revenue Growth Rate (2015-2020)
Figure 66. Global Tenofovir Revenue Growth Rate (2015-2020)
Figure 67. Global lamivudine Revenue Growth Rate (2015-2020)
Figure 68. Global Adefovir Revenue Growth Rate (2015-2020)
Figure 69. Global Telbivudine Revenue Growth Rate (2015-2020)
Figure 70. Global Others Revenue Growth Rate (2015-2020)
Figure 71. Global Hepatic Antiviral Drug Revenue Share by Application (2015-2020)
Figure 72. Global Hepatic Antiviral Drug Revenue Share by Application in 2019
Figure 73. Global Hepatic Antiviral Drug Market Share Forecast by Application (2021-2025)
Figure 74. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 75. Global Homecare Revenue Growth Rate (2015-2020)
Figure 76. Global Clinics Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Hepatic Antiviral Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Hepatic Antiviral Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Hepatic Antiviral Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
Figure 82. Europe Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
Figure 84. South America Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Hepatic Antiviral Drug Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
急性肝性ポルフィリン症治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Acute Hepatic Porphyria Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 抗ウイルス薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 47600 million by 2025, from USD 42060 million in 2019. The Antiviral Drugs market…
- 無菌・抗ウイルス包装の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Sterile and Antiviral Packaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 抗ウイルス経口液の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Antiviral Oral Liquid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- インフルエンザ（インフルエンザ）抗ウイルス薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Influenza (Flu) Antiviral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…